Well, this 5 Million may help the Co. through the end of the year. Final gasp waiting for the FDA. $2.90 is pretty cheap. USC probably will lose money and not produce any expected income, let alone any profits for ADMP. Only my opinions. Hope this Co. is around next year this time. Less than a 50/50 chance.
No support for this stock. Not even at this level. The day is far from over and it may fall to the $2.50 range.
It is now $0.16 pre RS. If it craters to below $0.14, this will be delisted by the end of the year and the story will be over and out.
Don;t know if it wouldl actual fall to $2.65 which was my original plan. But flipped a coin and ponied up some dough. My belief is it will bounce to $4.65+ then I'm out again.
Sell on the way up and sell on the way down. This stock is too speculative to do otherwise. Retail investors have been burned a number of times. Set your goals when you buy and remember pigs get fat while hogs get slaughtered. Unfortunately many are licking their wounds. When this hits &2.80 I might speculate again.
Well. I've watched his selling as well over the last 3 years. Lets just agree that he has never lost money and that in fact the shares have certainly been at the relative high of any 2 month trading period. Check it yourself.
The Arab owns at $0.25 a share I believe.....Oops I mean $4.25 a share. At $2.00 a share he will flip out in my opinion. Unless this is all just a trifle for him. Mylan should just scoop them up on the cheap now and be done with it. All just my opinion.
Love it. I wondered when some investors would go Gonzo. I believe some people really got hosed and just bought into the hype without checking. Easy come, easy go......and baby it went.
It hit $3.40 and below which was tempting to buy but I believe it will fall below $3.00 to around $0.16 a share pre RS. No one sees any value at this time in USC from what I can tell. If FDA approval ever comes we're looking at this time 2017. It remains a #$%$ shoot.
Drink that Kool-Aid Buddy. It all sounds great but the shorts ruled the day on this one.
Stock is continuing to crater. It may fall below 18 cents a share.....Oops, I mean $3.00 a share. So far no one seems to value the USC contribution and all that promised revenue. However, revenue does not always translate to profits. Can't cover up for failed management.
Well, after hours looks like $3.80. Pretty dismal I know. The rock bottom is $3.40 ( $0.20 PRS ) in my estimation. If it falls to this level, that is the time to buy again.
Sorry, corporations seeking FDA approval do not overlook or forget directives. They purposely made the decision to not comply and got slapped down again. This points to a lack of competency. Looks as if less energy should have been paid to close the deal with USC and all Energy used to comply. Make your own decision. But Carlo, the man on top, has to take the blame.
Hate to laugh at others misfortune, but hell you're all big boys and just admit you got roped in to a bad wet dream. Shorts made money so it was not all bad. Company may yet pull the rabbit out of the hat. Maybe in 1 to 2 years at best. For now it's over and back to $0.24 a share pre split. If ADMP didn't have USC then price might have crashed to $.09 or lower.
Incompetence.......take your pick from the dubious Carlo ( his history is well documented ) to the recent insider trading. It all adds up except to those still drinking the Kool-Aid.